Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onderstepoort Biological Products (OBP) is a South African state-owned biotechnology company specializing in the development and manufacture of veterinary vaccines and diagnostic reagents. Established in 2000 from the research roots of the Onderstepoort Veterinary Institute, the company serves the livestock and companion animal markets across Africa and internationally. Its product portfolio includes over 50 vaccines targeting critical diseases such as African Horse Sickness, Bluetongue, and Lumpy Skin Disease. OBP plays a vital role in food security and animal health by providing affordable, high-quality biological products to prevent and control infectious diseases. The company operates a large-scale manufacturing facility in Pretoria, South Africa, and is a key partner for government-led disease control programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onderstepoort Biological Products.